Search Results

You are looking at 71 - 80 of 117 items for :

  • Cushing���s disease x
  • Refine by Access: All content x
Clear All
Open access

Vittorio Unfer, Fabio Facchinetti, Beatrice Orrù, Barbara Giordani, and John Nestler

.33 ± 5.2023.79 ± 4.24 PCOS according to the Rotterdam criteria Smoking, hyperprolactinemia, hypogonadotropic hypogonadism, pregnancy, thyroid disease, congenital adrenal hyperplasia, androgen-secreting tumors and Cushing’s syndrome N MI + FA vs

Open access

Ladan Younesi, Zeinab Safarpour Lima, Azadeh Akbari Sene, Zahra Hosseini Jebelli, and Ghazaleh Amjad

. People with Cushing’s syndrome and people who have undergone hormonal treatments during the past 6 months. The reasons for the exclusion of subjects from the plan was recorded as clear as possible to determine the impact of them and the probable

Open access

Milica Popovic, Fahim Ebrahimi, Sandrine Andrea Urwyler, Marc Yves Donath, and Mirjam Christ-Crain

triglycerides >1.7 mmol/L or low-density-lipoprotein-cholesterol (LDL-C) >3.4 mmol/L or lipid lowering treatment). Main exclusion criteria were concurrent medication with glucocorticoids, known Cushing’s syndrome, an underlying chronic inflammatory disease

Open access

A V Dreval, I V Trigolosova, I V Misnikova, Y A Kovalyova, R S Tishenina, I A Barsukov, A V Vinogradova, and B H R Wolffenbuttel

– 152 . ( doi:10.1210/er.2002-0022 ). 3 Biering H Knappe G Gerl H Lochs H . Prevalence of diabetes in acromegaly and Cushing syndrome . Acta Medica Austriaca 2000 27 27 – 31 . ( doi:10.1046/j.1563-2571.2000.00106.x ). 4 Kasayama S

Open access

Siphiwe N Dlamini, Zané Lombard, Lisa K Micklesfield, Nigel Crowther, Shane A Norris, Tracy Snyman, Andrew A Crawford, Brian R Walker, and Julia H Goedecke

cortisol leads to Cushing’s syndrome, which exhibits metabolic features similar to metabolic syndrome ( 2 ). Accordingly, previous cross-sectional studies suggest that circulating cortisol concentrations are associated with metabolic syndrome, its

Open access

Filippo Ceccato, Elisa Selmin, Giorgia Antonelli, Mattia Barbot, Andrea Daniele, Marco Boscaro, Mario Plebani, and Carla Scaroni

, without medical treatment), unexplained hyponatremia (<134 nmol/L), unexplained hypoglycemia in patients not using anti-diabetic drugs, salt craving, fatigue; - HPA axis suppression after remission of endogenous Cushing’s syndrome (CS) or after

Open access

Jia Li, Yan Zhao, Caoxin Huang, Zheng Chen, Xiulin Shi, Long Li, Zhong Chen, and Xuejun Li

Kroiss M Berr CM Stalla G Fassnacht M Adamski J , Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing’s syndrome . European Journal of Endocrinology 2017 177 227 – 237 . (

Open access

Milène Tetsi Nomigni, Sophie Ouzounian, Alice Benoit, Jacqueline Vadrot, Frédérique Tissier, Sylvie Renouf, Hervé Lefebvre, Sophie Christin-Maitre, and Estelle Louiset

Jong FH . Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome . European Journal of Endocrinology 2013 168 67 – 74 . ( doi:10

Open access

Ana Podbregar, Tomaž Kocjan, Matej Rakuša, Peter Popović, Manca Garbajs, Katja Goricar, Andrej Janez, and Mojca Jensterle

to January 2011 and were characterized as NFAI. NFAI was confirmed when cortisol after 1 mg overnight dexamethasone suppression test (ODST) was < 50 nmol/L, no typical clinical signs of Cushing’s syndrome were present and pheochromocytoma and primary

Open access

Henrik Falhammar, Magnus Kjellman, and Jan Calissendorff

.1210/JC.2015-2093 10 Falhammar H Calissendorff J Hoybye C. Frequency of Cushing’s syndrome due to ACTH-secreting adrenal medullary lesions: a retrospective study over 10 years from a single center . Endocrine 2017 55 296 – 302 . ( https